Patent technology breakthrough! Guilin Royalyze Medical blood glucose analyzer achieves dual index interference free synchronous detection
Release time:
2025-10-27
To solve the industry problem of mutual interference in multi indicator detection, Guilin Royalyze Medical Equipment Co., Ltd. (hereinafter referred to as Royalyze Medical") recently launched a new generation of blood glucose analyzer equipped with patented technology, which has attracted widespread attention in the clinical field with its core advantages of "one-time injection and dual precision". This device is based on the patented technology of "eliminating mutual interference between two biochemical substances in a single injection detection biosensor", which enables synchronous and accurate measurement of blood glucose and uric acid indicators. The detection error rate is controlled within ± 3%, which is 50% more efficient than traditional devices.
To solve the industry problem of mutual interference in multi indicator detection, Guilin Royalyze Medical Equipment Co., Ltd. (hereinafter referred to as Royalyze Medical") recently launched a new generation of blood glucose analyzer equipped with patented technology, which has attracted widespread attention in the clinical field with its core advantages of "one-time injection and dual precision". This device is based on the patented technology of "eliminating mutual interference between two biochemical substances in a single injection detection biosensor", which enables synchronous and accurate measurement of blood glucose and uric acid indicators. The detection error rate is controlled within ± 3%, which is 50% more efficient than traditional devices.
The technological breakthrough of this blood glucose analyzer is reflected in its unique dual channel detection design: the device is equipped with two independent sample channels and an enzyme reaction layer, which transfer trace amounts of blood samples (only 2 microliters) to dedicated reaction zones through siphon action. Combined with the working electrode and impedance recognition system set at the front end, it completely eliminates electrical signal interference between the two detection systems. The clinical test showed that the consistency between the test results and the HPLC method was 99.2%, and it could resist the interference of six common drugs, such as vitamin C and paracetamol. It was suitable for the daily monitoring of diabetes patients with hyperuricemia.
In the past, measuring blood glucose and uric acid required two devices and two blood samples, but now two results can be obtained in 30 seconds, "said the R&D director of Guilin Royalyze Medical. The analyzer is also equipped with a 10.1-inch touch screen and an embedded data management system, which can automatically generate blood glucose reports for multiple periods such as fasting and 2 hours after meals. It supports USB and Bluetooth dual-mode data export and has passed ISO13485 system certification and clinical verification in tertiary hospitals. With the market size of blood glucose meters in China surpassing 24 billion yuan by 2025, this type of multi parameter precision detection equipment is becoming the core force for domestic substitution.
Contact
E-mail：aachek@aachek.com
Phone：tel:+8618290008018
ADD : 13 Lushan Road, Lushan Industrial Park, Xicheng Economic Development Zone, Guilin, 541199 Guangxi PR. China
Mobile
Powered by www.300.cn SEO